Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Single-cell image-based screens identify host regulators of Ebola virus infection dynamics.

Nature microbiology·2025

Same author

Classification and functional characterization of regulators of intracellular STING trafficking identified by genome-wide optical pooled screening.

Cell systems·2024

Same author

Classification and functional characterization of regulators of intracellular STING trafficking identified by genome-wide optical pooled screening.

bioRxiv : the preprint server for biology·2024

Same author

Single-cell image-based genetic screens systematically identify regulators of Ebola virus subcellular infection dynamics.

bioRxiv : the preprint server for biology·2024

Same author

Human STING is a proton channel.

Science (New York, N.Y.)·2023

Same author

A genome-wide optical pooled screen reveals regulators of cellular antiviral responses.

Proceedings of the National Academy of Sciences of the United States of America·2023

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Current developments in pharmacogenomics of multiple sclerosis.

Rebecca J Carlson¹, J Ronald Doucette, Adil J Nazarali

¹Laboratory of Molecular Cell Biology, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 5C9, Canada.

Cellular and Molecular Neurobiology

|August 15, 2014

Summary

This summary is machine-generated.

Pharmacogenomics enables personalized medicine by matching treatments to genetic profiles, improving health outcomes and reducing side effects. This approach minimizes trial-and-error treatments for diseases like multiple sclerosis.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Related Experiment Videos

Last Updated: Apr 25, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

Area of Science:

Genetics
Pharmacology
Neurology

Background:

Pharmacogenomics offers personalized medicine by targeting genetically identifiable populations.
This approach promises improved health outcomes with fewer side effects.
It aims to eliminate the 'trial and error' method in disease treatment.

Purpose of the Study:

To provide an overview of recent advancements in the pharmacogenomics of multiple sclerosis.
To explore the potential of these developments in improving future treatment strategies.

Main Methods:

Review of current literature on pharmacogenomics and multiple sclerosis.
Analysis of emerging therapeutic targets and genetic markers.
Synthesis of findings to project future treatment possibilities.

Main Results:

Pharmacogenomic strategies are emerging for multiple sclerosis treatment.
Personalized interventions show potential for enhanced efficacy and safety.
Genetic profiling can guide treatment selection, moving beyond generalized approaches.

Conclusions:

Pharmacogenomics holds significant potential to revolutionize multiple sclerosis treatment.
Personalized medicine approaches promise more effective and safer therapies.
Future treatments will likely be guided by individual genetic makeup for better patient outcomes.